ITRACONAZOLE DUSTING POWDER

FUNGIVICE DUSTING POWDER

COMPOSITION
ITRACONAZOLE DUSTING POWDER1%
SPECIFICATION
FORMPOWDER
PACKING 75GM
PACKING TYPEDUSTING POWDER
MRP180

DESCRIPTION

One of the triazole antifungal agents that inhibits cytochrome P-450-dependent enzymes resulting in impairment of ergosterol synthesis. It has been used against histoplasmosis, blastomycosis, cryptococcal meningitis & aspergillosis. [PubChem]

SIDE EFFECTS

No significant lethality was observed when itraconazole was administered orally to mice and rats at dosage levels of 320 mg/kg or to dogs at 200 mg/kg.

INDICATION

For the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: pulmonary and extrapulmonary blastomycosis, histoplasmosis, aspergillosis, and onychomycosis.